Oculus Receives Patent On Microcyn Technology For Atopic Dermatitis

Shares of OCLS are up 10+% after announcing a patent for its Microcyn Technology for treating atopic dermatitis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.